Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 19-Jun-2013
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 18)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
19-Jun-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical-generic Drugs17$195.50  View Abstract
13-Jun-13ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for SUPN11$126.50  View Abstract
11-Jun-13Zacks Investment Research Inc.N/ASUPERNUS PHARMA (SUPN) Zacks Company Snapshot1$11.50  View Abstract
10-Jun-13Wright ReportsN/AWright Investors Service Comprehensive Report for Supernus Pharmaceuticals Inc33$379.50  View Abstract
9-Jun-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SUPERNUS PHARMACEUTICALS INC (SUPN)5$10  View Abstract
4-Jun-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SUPERNUS PHARMACEUTICALS INC (SUPN)5$10  View Abstract
3-Jun-13Zacks Investment Research Inc.N/ASUPERNUS PHARMA (SUPN) Zacks Company Snapshot1$11.50  View Abstract
31-May-13Zacks Investment Research Inc.N/ASUPERNUS PHARMA (SUPN) Zacks Company Snapshot1$11.50  View Abstract
29-May-13Zacks Investment Research Inc.N/ASUPERNUS PHARMA (SUPN) Zacks Company Snapshot1$11.50  View Abstract
24-May-13Zacks Investment Research Inc.N/ASUPERNUS PHARMA (SUPN) Zacks Company Snapshot1$11.50  View Abstract
Next 8

Independent Reports (Showing 1 to 10 of 18)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
19-Jun-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical-generic Drugs17$195.50View Abstract
13-Jun-13ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for SUPN11$126.50View Abstract
11-Jun-13Zacks Investment Research Inc.N/ASUPERNUS PHARMA (SUPN) Zacks Company Snapshot1$11.50View Abstract
10-Jun-13Wright ReportsN/AWright Investors Service Comprehensive Report for Supernus Pharmaceuticals Inc33$379.50View Abstract
9-Jun-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SUPERNUS PHARMACEUTICALS INC (SUPN)5$10View Abstract
4-Jun-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SUPERNUS PHARMACEUTICALS INC (SUPN)5$10View Abstract
3-Jun-13Zacks Investment Research Inc.N/ASUPERNUS PHARMA (SUPN) Zacks Company Snapshot1$11.50View Abstract
31-May-13Zacks Investment Research Inc.N/ASUPERNUS PHARMA (SUPN) Zacks Company Snapshot1$11.50View Abstract
29-May-13Zacks Investment Research Inc.N/ASUPERNUS PHARMA (SUPN) Zacks Company Snapshot1$11.50View Abstract
24-May-13Zacks Investment Research Inc.N/ASUPERNUS PHARMA (SUPN) Zacks Company Snapshot1$11.50View Abstract
Next 8

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.